Canine Hemangiosarcoma Cell Line (DHSA-1426)

DHSA-1426 is a canine hemangiosarcoma cell line derived from a tumor in the spleen of a 10-year old neutered male Golden Retriever. The cell line was derived from material obtained during a therapeutic splenectomy. This cell line grows in vitro, and it reproducibly forms hemangiosarcoma xenografts in immunodeficient mice when injected subcutaneously in Matrigel.

Hemangiosarcoma is a rapidly growing, highly invasive variety of cancer, occurring commonly in dogs. It is a sarcoma arising from the lining of blood vessels. A frequent cause of death is the rupturing of this tumor, causing the patient to rapidly bleed to death.

From the laboratory of Jaime F. Modiano, VMD, PhD, University Minnesota, Twin Cities.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EMN017-FP
Canine Hemangiosarcoma Cell Line (DHSA-1426)
1 vial In stock
Regular Price:$605.00
On Sale:

This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.

Specifications

Product Type: Cell Line
Name: DHSA-1426
Cell Type: Hemangiosarcoma
Morphology: Spindle
Organism: Dog
Source: Spleen, The cell line was derived from material obtained during a therapeutic splenectomy.
Biosafety Level: 2
Growth Conditions: Ham's F12, 10% FBS, 0.05mg/ml ECGS, 0.01mg/ml heparin, 10mM HEPES Buffer, 100ug/ml Primocin
Subculturing: Doubling time approx. 24 hours, Split 1:3-1:5 when cells reach ~80% confluence.
Cryopreservation: 90%FBS/10% DMSO
Mycoplasma Tested: Yes
Comments: This cell line grows in vitro, and it reproducibly forms hemangiosarcoma xenografts in immunodeficient mice when injected subcutaneously in Matrigel.
Storage: Liquid nitrogen
Shipped: Dry Ice

Provider
From the laboratory of Jaime F. Modiano, VMD, PhD, University Minnesota, Twin Cities.
Loading...